Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1344 ARTÍCULOS , VIENDO DEL 1261 AL 1275

Comparison of clinical characteristics between familial and non-familial early onset Alzheimer's disease

Karve SJ, Ringman JM, Lee AS, Juarez KO, Mendez MF.

J Neurol. 2012 Oct;259(10):2182-8. doi: 10.1007/s00415-012-6481-y. Epub 2012 Mar 30.

Autosomal dominant Alzheimer's disease with early frontal lobe involvement associated with the Met239Ile mutation of Presenilin 2 gene

Testi S, Fabrizi GM, Pompanin S, Cagnin A.

J Alzheimers Dis. 2012;31(1):7-11. doi: 10.3233/JAD-2012-120280.

Phenotypic profile of early-onset familial Alzheimer's disease caused by presenilin-1 E280A mutation

Sepulveda-Falla D, Glatzel M, Lopera F.

J Alzheimers Dis. 2012;32(1):1-12. doi: 10.3233/JAD-2012-120907.

Differential putaminal morphology in Huntington's disease, frontotemporal dementia and Alzheimer's disease

Looi JC, Rajagopalan P, Walterfang M, Madsen SK, Thompson PM, Macfarlane MD, Ching C, Chua P, Velakoulis D.

Aust N Z J Psychiatry. 2012 Dec;46(12):1145-58. doi: 10.1177/0004867412457224. Epub 2012 Sep 18.

Seizures in juvenile Huntington's disease: frequency and characterization in a multicenter cohort

Cloud LJ, Rosenblatt A, Margolis RL, Ross CA, Pillai JA, Corey-Bloom J, Tully HM, Bird T, Panegyres PK, Nichter CA, Higgins DS Jr, Helmers SL, Factor SA, Jones R, Testa CM.

Mov Disord. 2012 Dec;27(14):1797-800. doi: 10.1002/mds.25237. Epub 2012 Nov 2.

[Schizophrenia-like psychotic symptoms in a patient with confirmed Huntington's disease: a case report]

Grabski B, Siwek M, Dudek D, Jaeschke R, Banaszkiewicz K.

Psychiatr Pol. 2012 Jul-Aug;46(4):665-75.

[Is Huntington's disease a neurological or psychiatric disorder? case report]

Dubas-Slemp H, Tylec A, Michałowska-Marmurowska H, Spychalska K.

Psychiatr Pol. 2012 Sep-Oct;46(5):915-22.

N-methyl D-aspartate (NMDA) receptor antagonists and memantine treatment for Alzheimer's disease, vascular dementia and Parkinson's disease

Olivares D, Deshpande VK, Shi Y, Lahiri DK, Greig NH, Rogers JT, Huang X.

Curr Alzheimer Res. 2012 Jul;9(6):746-58. doi: 10.2174/156720512801322564.

Prodromal dementia with lewy bodies manifesting as sertraline-induced parkinsonism: a case report

Kim JH, Park J, Yu KH, Ma HI, Lee BC, Kim I, Kim YJ.

Alzheimer Dis Assoc Disord. 2012 Apr-Jun;26(2):191-3. doi: 10.1097/WAD.0b013e318231a896.

Mild cognitive impairment associated with underlying Alzheimer's disease versus Lewy body disease

Boeve BF.

Parkinsonism Relat Disord. 2012 Jan;18 Suppl 1:S41-4. doi: 10.1016/S1353-8020(11)70015-3.

Immunopathogenesis of neurodegenerative diseases: current therapeutic models of neuroprotection with special reference to natural products

Magrone T, Marzulli G, Jirillo E.

Curr Pharm Des. 2012;18(1):34-42. doi: 10.2174/138161212798919057.

Dementia is associated with insulin resistance in patients with Parkinson's disease

Bosco D, Plastino M, Cristiano D, Colica C, Ermio C, De Bartolo M, Mungari P, Fonte G, Consoli D, Consoli A, Fava A.

J Neurol Sci. 2012 Apr 15;315(1-2):39-43. doi: 10.1016/j.jns.2011.12.008. Epub 2012 Jan 21.

Comparative platelet proteome analysis reveals an increase of monoamine oxidase-B protein expression in Alzheimer's disease but not in non-demented Parkinson's disease patients

Zellner M, Baureder M, Rappold E, Bugert P, Kotzailias N, Babeluk R, Baumgartner R, Attems J, Gerner C, Jellinger K, Roth E, Oehler R, Umlauf E.

J Proteomics. 2012 Apr 3;75(7):2080-92. doi: 10.1016/j.jprot.2012.01.014. Epub 2012 Jan 17.

Activation of the unfolded protein response is an early event in Alzheimer's and Parkinson's disease

Hoozemans JJ, van Haastert ES, Nijholt DA, Rozemuller AJ, Scheper W.

Neurodegener Dis. 2012;10(1-4):212-5. doi: 10.1159/000334536. Epub 2012 Feb 1.

Effects of natural antioxidants in neurodegenerative disease

Albarracin SL, Stab B, Casas Z, Sutachan JJ, Samudio I, Gonzalez J, Gonzalo L, Capani F, Morales L, Barreto GE.

Nutr Neurosci. 2012 Jan;15(1):1-9. doi: 10.1179/1476830511Y.0000000028.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias